(2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol
C20H21N7O — CID 139468791
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol
(2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol (PubChem CID 139468791) has the molecular formula C20H21N7O and a molecular weight of 375.44 g/mol. Its IUPAC name is (2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol.
Molecular Properties
| Compound Name | (2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol |
|---|---|
| PubChem CID | 139468791 |
| Molecular Formula | C20H21N7O |
| Molecular Weight | 375.44 g/mol |
| Exact Mass | 375.18 |
| IUPAC Name | (2S)-2-[4-[[8-amino-6-(4-methyl-3-pyridinyl)-2,7-naphthyridin-3-yl]amino]pyrazol-1-yl]propan-1-ol |
| SMILES | Cc1ccncc1-c1cc2cc(Nc3cnn([C@@H](C)CO)c3)ncc2c(N)n1 |
| InChI | InChI=1S/C20H21N7O/c1-12-3-4-22-8-16(12)18-5-14-6-19(23-9-17(14)20(21)26-18)25-15-7-24-27(10-15)13(2)11-28/h3-10,13,28H,11H2,1-2H3,(H2,21,26)(H,23,25)/t13-/m0/s1 |
| InChIKey | GJMWANQGFGNJEQ-ZDUSSCGKSA-N |
| XLogP | 3.08 |
| TPSA | 114.77 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 375.44 |
| LogP ≤ 5 | 3.08 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139468791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.